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OBJECTIVES The study evaluated the contribution of familial predisposition to the risk of left ventricular
hypertrophy (LVH).
BACKGROUND Left ventricular hypertrophy is a multifactorial condition that serves as an important predictor
of cardiovascular mortality. At present it is unclear whether familial predisposition contributes
to the manifestation of LVH. Thus, we determined whether siblings of subjects with LVH
are at increased risk to present with an elevation of LV mass or an abnormal LV geometry.
METHODS Echocardiographic and anthropometric measurements were performed in 2,293 individuals
who participated in the echocardiographic substudies of population-based MONICA
Augsburg surveys. In addition, a total of 319 siblings of survey participants with echocar-
diographic evidence of LVH were evaluated. The risk of these siblings to present with LVH
or abnormal LV geometry was estimated by comparison with 636 subjects matched for gender
and age that were selected from the entire echocardiography study base.
RESULTS Blood pressure, body mass index, age, and gender (i.e., known determinants of LV mass) were
comparable in LVH-siblings and the matched comparison group. However, septal and
posterior wall thicknesses, relative wall thickness as well as LV mass index were significantly
elevated in LVH-siblings (p , 0.001, each) whereas LV dimensions did not differ. Likewise,
the prevalence of LVH was raised in LVH-siblings, as was the relative risk of LVH after
adjustment for confounders (p , 0.05). More specifically, LVH-siblings displayed increased
prevalences of concentric remodeling and concentric LVH (p , 0.05) but not of eccentric
LVH.
CONCLUSIONS Familial predisposition appears to contribute to increased LV wall thickness, to the
development of LV hypertrophy and abnormal LV geometry. (J Am Coll Cardiol 1999;33:
1685–91) © 1999 by the American College of Cardiology
Left ventricular hypertrophy (LVH) is of heterogeneous
etiology, with hypertension and obesity being principal
determinants of this major cardiovascular risk factor (1,2).
Interestingly, the manifestation of both arterial hyperten-
sion and morbid obesity is partially related to a genetic
predisposition (3,4). In particular, studies on twins indicated
that up to 50% of blood pressure variability and 70% of body
mass index variability may be determined by inherited
factors (3,4). Likewise, there is growing evidence from
studies on juvenile twins that left ventricular wall thickness
or left ventricular mass (LVM) displays only minimal
variance in subjects with identical genetic background (3,5–
8). Furthermore, recent analyses of the Framingham Heart
Study document significant intraclass correlations of LVM
in first-degree relatives and identified a small but discernible
proportion of its variance as being due to heredity (9).
However, the impact of a familial predisposition on the
manifestation of LVH has never been examined specifically.
We thus investigated the hypothesis that siblings of subjects
with LVH have an increased LV mass and a higher risk to
develop LVH.
SUBJECTS AND METHODS
Study population. The study was set up as a part of the
World Health Organization MONICA project (10) to
monitor trends and determinants of cardiovascular morbid-
ity and mortality in the city of Augsburg and two adjacent
counties in southern Germany. In 1984 to 1985, 1989 to
1990 and 1994 to 1995, three surveys were conducted
selecting independent, age-stratified random samples of the
population for assessment of the risk factor profile (11). All
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individuals who participated in this study gave written
informed consent.
Echocardiographic substudies were performed to further
evaluate electrocardiographic data suggesting that inherita-
ble factors are involved in the pathogenesis of LVH (12). In
1994, participants of the 1984 to 1985 survey were reinvited
for an echocardiographic examination. The invitation was
restricted to subjects 52 to 67 years of age, and 646 men and
women (response 64%) could be examined (13–15). In
addition, echocardiographic examinations were offered to all
participants of the 1994/1995 survey attending the Augs-
burg study center. Thereby, another 1,678 men and women
in the age range from 25 to 74 years (response 70.6%) could
be examined (16).
All participants of the two echocardiographic substudies
who displayed LVH by echocardiography (LVM indexed to
body height .143 g/m in men and .102 g/m in women;
n 5 427) were interviewed about the number and gender of
their living siblings. Whenever study participants and their
siblings agreed, siblings were invited to participate in the
examinations applying the same study protocol. A total of
373 male and female siblings were subsequently examined.
From all 2,293 participants of the echocardiographic
substudies and all LVH-siblings, data on medical history,
medication, and smoking or drinking behavior were ob-
tained by interviews. Subjects’ body height and weight were
measured in light clothing and without wearing shoes, and
the body mass index (BMI) was computed as weight in
kilograms divided by height in meters squared (kg/m2).
Resting blood pressure was measured before and after
echocardiography using a standard mercury sphygmoma-
nometer. Blood pressure was read three times at the right
arm, and the mean of all three measurements was used in
this study. Hypertension was defined as blood pressure
values equal or above systolic 160 mm Hg and/or diastolic
95 mm Hg, or as present in subjects chronically taking
antihypertensive medication.
Echocardiographic measurements. Two-dimensional
guided M-mode echocardiograms were obtained from each
subject by one of three expert sonographers with a Sonos
1500 (Hewlett-Packard, Andover, Massachusetts). The
M-mode tracings were recorded on strip chart paper at
50 mm/s, given a code number and analyzed without
knowledge on whether the echocardiogram was from a
LVH-sibling or a control subject. Only tracings that dem-
onstrated optimal visualization of left ventricular interfer-
ences were used. Measurements of wall thicknesses and
ventricular diameters for the calculation of LVM were made
in random order on coded strip charts without knowledge of
whether the recording was from a sibling or a matched
subject. Left ventricular internal end-diastolic diameter
(EDD), septal wall thickness (SWT), and posterior wall
thickness (PWT) were measured according to the Penn
convention just below the tip of the mitral valve as recom-
mended by the American Society of Echocardiography (17).
Left ventricular mass (LVM) was calculated according to
the formula of Devereux et al. (18):
LVM ~in grams! 5 ~1.04 @EDD 1 SWT 1 PWT#3
2 EDD3) 2 13.6 g.
The LVM indexed to body size (LVMI) was obtained in
three different ways: it was either divided by body height in
meters (19), by the allometric signal height2.7 (20), or by
body surface area in meters squared (19). The following
LVH criteria for each indexation method were used: LVM
indexed to height: .143 g/m in men, .102 g/m in women
(19); LVM indexed to body surface area: .131 g/m2 in
men, .100 g/m2 in women (19); LVM indexed to
height2.7: .50 g/m2.7 in men, .47 g/m2.7 in women (20).
Patterns of left ventricular geometry were defined as pro-
posed by Ganau et al. (21)—that is, as normal geometry
when LVMI was normal and relative wall thickness
(RWT 5 2 PWT/EDD) ,0.45; as left ventricular remod-
eling when normal LVMI was combined with RWT
.0.45; as concentric LVH when left ventricular hypertro-
phy occurred with a RWT .0.45; and as eccentric LVH
when left ventricular hypertrophy and a RWT ,0.45 were
combined.
Statistical analyses. To investigate the influence of familial
predisposition on risk of LVH we used a method proposed
by Weis et al. (22,23). We compared each sibling with two
control subjects from the population-based echocardio-
graphic substudies of the MONICA Augsburg project. For
this purpose, each LVH-sibling was randomly matched
with two individuals of the same gender and five-years’ age
group. We thus avoided a direct comparison of sibling pairs
(i.e., correlation analysis), which might be criticized for the
fact that various factors can introduce high correlations
between siblings rather indirectly (with respect to the
heart—e.g., body size) or may be explained by factors
beyond inheritance (“shared environment” in a large sense).
By distinction, we examined in our study design how the
“exposure” of individuals to familial predisposition, defined
as having a sibling diagnosed with LVH, may relate to left
ventricular mass and hypertrophy aside from the amount
contributed by age, gender, body mass, and blood pressure.
The latter factors were controlled by design either through
appropriate matching (age, gender) or through statistical
adjustment (BMI and systolic blood pressure).
Abbreviations and Acronyms
BMI 5 body mass index
EDD 5 end-diastolic diameter
LVH 5 left ventricular hypertrophy
LVM(I) 5 left ventricular mass (index)
PWT 5 posterior wall thickness
RWT 5 relative wall thickness
SWT 5 septal wall thickness
1686 Schunkert et al. JACC Vol. 33, No. 6, 1999
Familial Risk for LVH May 1999:1685–91
Echocardiographic tracings that demonstrated optimal
visualization of left ventricular inferences and a complete set
of analytic variables were obtained from 319 LVH-siblings
(85% of the total of 373 examined) and from 1,923
individuals from the survey samples (84% of the total of
2,293). Excluded subjects were significantly older, more
obese and more often men (each p , 0.01). The analyses in
this report are based on a comparison 319 LVH-siblings
with 636 subjects who were randomly selected after success-
ful matching by gender and age group.
The description of baseline data compares the mean
values of age, blood pressure, and body size between
LVH-siblings and the comparison group. The statistical
significance of differences in continuous variables was as-
sessed by two-sided t tests for unpaired groups and for
categorized variables by chi-square tests. Mean values of
echocardiographic measurements were compared after ad-
justment for age, gender, systolic blood pressure, and BMI
by means of multiple linear regression modeling (PROC
GLM of the SAS statistical software, Version 6.11). Fur-
thermore, the prevalences of LVH using indexations for
body height, height2.7, and body surface area were assessed.
Multiple logistic regression was applied to estimate the ratio
of the LVH odds in LVH-siblings and their comparisons
controlling for age, gender, systolic blood pressure, and
BMI. The 95% confidence intervals are reported as a
measure of the precision of the odds ratio estimates. Finally,
the geometric patterns of LVH were analyzed in both
siblings and controls. The odds ratio for the occurrence of a
concentric pattern (relative wall thickness .0.45) was esti-
mated by logistic regression controlling for covariates.
RESULTS
Baseline characteristics. Table 1 displays the mean values
of body size, blood pressure as well as the proportion of
individuals taking antihypertensive medication in the survey
population as well as in LVH-siblings and the matched
comparison group. Statistical analysis, carried out between
LVH-siblings and the matched comparison group, did not
display any significant differences with respect to any of
these variables, which are known determinants of LV mass
and hypertrophy.
Echocardiographic measurements. There were marked
differences in cardiac structure and geometry of LVH-
siblings and matched controls (Table 2). After adjustment
for age, gender, systolic blood pressure and BMI, the
interventricular septum and the posterior ventricle wall were
significantly thicker in LVH-siblings (p , 0.001). This
contrasted with the lack of any discernible differences in the
internal end-diastolic dimensions. Consequently, the rela-
tive wall thickness was significantly raised in siblings (p ,
Table 1. Mean Values (and Standard Errors) and Percentages of Baseline Characteristics in LVH-Siblings and a Comparison Group
Matched by Age and Gender
Survey
Participants
(n 5 1,923)
LVH-
Siblings
(n 5 319)
Comparison
Group
(n 5 636)
LVH-Siblings vs.
Comparison
Group p-Value
Male (%) 48.7 45.2 45.2 0.98
Age (yrs) 51.5 (0.2) 55.2 (0.6) 55.5 (0.4) 0.68
Body height (cm) 167.0 (0.2) 167.1 (0.5) 166.8 (0.4) 0.60
Body surface area (m2) 1.83 (0.01) 1.86 (0.01) 1.84 (0.01) 0.20
Body mass index (kg/m2) 26.7 (0.09) 27.5 (0.3) 27.1 (0.2) 0.16
Systolic BP (mm Hg) 144.4 (0.5) 148.1 (1.3) 149.3 (0.9) 0.45
Diastolic BP (mm Hg) 87.1 (0.3) 90.9 (0.8) 89.9 (0.5) 0.24
Antihypertensive medication (%) 14 19 22 0.22
Values are expressed as mean 6 SEM; systolic and diastolic BP represent respective blood pressures.
Table 2. Adjusted Mean Values (and Standard Errors) of Echocardiographic Measurements in LVH-Siblings and a Comparison
Group Matched by Age and Gender
Survey
Participants
(n 5 1,923)
LVH-
Siblings
(n 5 319)
Comparison
Group
(n 5 636)
LVH-Siblings vs.
Comparison
Group p-Value
Septal wall thickness (mm) 10.6 (0.05) 11.6 (0.11) 10.9 (0.08) , 0.001
Posterior wall thickness (mm) 8.7 (0.04) 9.5 (0.07) 8.9 (0.05) , 0.001
End-diastolic diameter (mm) 48.0 (0.11) 47.7 (0.25) 48.1 (0.18) 0.18
Relative wall thickness (%) 38.1 40.2 37.7 , 0.001
LVM/height (g/m) 104.3 (0.83) 114.6 (1.6) 109.1 (1.1) 0.0035
LVM/BSA (g/m2) 94.4 (0.67) 103.0 (1.4) 98.1 (0.9) 0.0041
LVM/height2.7 (g/m2.7) 43.5 (0.34) 47.8 (0.7) 45.8 (0.5) 0.012
LVM represents left ventricular mass; BSA, body surface area.
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0.001). Finally, the LV masses of LVH-siblings were
elevated irrespective of the type of indexation used (p 5
0.012 or less).
Prevalence of LVH. The LVH prevalence in siblings was
between 5% and 10% higher than in the matched compar-
ison group, and the odds ratios for LVH were significantly
raised among siblings (Table 3). The odds ratio was most
pronounced when LVM indexed to height2.7 was used in
the definition of LVH (OR 5 1.7, 95% confidence interval
1.25–2.42, p 5 0.001), whereas it was 1.4 with the other
indexations (each p , 0.05). A more specific analysis
revealed that the increased LVH prevalence of siblings was
caused exclusively by increased rates of remodeling and
concentric LVH (Fig. 1). The odds ratio for the joint
presence of these two conditions, which is synonymous with
the prevalence of a relative wall thickness .45%, was 1.98
(95% confidence interval 1.47–2.68; p 5 0.001) among
siblings relative to the matched comparison group. The
LVH-siblings presented with a significantly elevated odds
ratio for an increased relative wall thickness irrespective of
substratification by normal or elevated blood pressure or
normal or elevated body weight, respectively (Table 4).
DISCUSSION
Genetic analyses on juvenile twins have established that the
interindividual variability of left ventricular mass is strongly
determined by inherited factors (3,7,8). Furthermore, data
from the Framingham Heart Study display better intraclass
Figure 1. The bar graph displays the prevalence of various left ventricular geometries in siblings of subjects with LVH and matched
controls. Remodeling and concentric LVH were significantly more prevalent in LVH-siblings, the opposite was true for normal LV
geometry (p , 0.05, each). Solid bars 5 siblings; open bars 5 matched control groups.
Table 3. Prevalence (in %) and Adjusted Odds Ratio of LVH in LVH-Siblings and A
Comparison Group Matched by Age and Gender, Applying Three Different Indexations of Left
Ventricular Mass
LVH by Indexation type
LVH-Siblings
(n 5 319)
Matched
Controls
(n 5 636) p-Value
Prevalence (LVM/height: m .143
g/m, f .102 g/m)
37.9% 32.7%
Adjusted odds ratio of LVH 95%
confidence interval
1.4 (1.004–1.954) 2* 0.047
Prevalence (LVM/BSA: m .131
g/m2, f .100 g/m2)
30.4% 25.4%
Adjusted odds ratio of LVH 95%
confidence interval
1.4 (1.031–2.015) 2* 0.033
Prevalence (LVM/height2.7: m .50
g/m2.7, f .47 g/m2.7)
44.5% 34.9%
Adjusted odds ratio of LVH 95%
confidence interval
1.7 (1.249–2.423) 2* 0.001
*Reference category.
m 5 male; f 5 female; LVM 5 left ventricular mass; LVMI 5 indexed LVM; BSA 5 body surface area. Adjusted by
multiple logistic regression models containing gender, age, systolic blood pressure and body mass index.
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correlations of left ventricular mass in first-degree relatives
as compared to second-degree relatives or spouses (9). It is
very intriguing to extrapolate these data to LVH, a highly
recognized cardiovascular risk factor in middle-aged or
elderly adults (24,25). However, long-term interaction of
environmental factors might overcome genetic effects in the
pathogenesis of LVH. Therefore, it is presently unclear
whether familial predisposition is also a risk factor for the
development of LVH. To study this question, we identified
siblings of subjects with LVH and compared their odds to
present with LVH with that of matched controls. Our
principal finding is that the risk of LVH is substantially
increased in siblings of affected individuals.
LVH a familial risk factor. After adjustment for age,
blood pressure, and BMI, the risk elevation related to a
familial disposition of LVH was 1.4 to 1.7. This proportion
compares favorably to that calculated in recent twin studies
for the genetic component of LVM variability (3,6–8). It
needs to be pointed out, however, that the present data do
not allow one to distinguish whether the elevated risk of
LVH is related to the fact that the siblings shared genes,
environment, or both (3,5–8,26). Nevertheless, the consid-
eration of both—twin studies and the present investigation
on siblings of subjects with LVH—allows the hypothesis
that LVH is modulated, in part, by an inherited component.
This view is strengthened by a small but significant effect of
heredity on LVM observed in adult siblings of the Framing-
ham Heart Study (9). Furthermore, the present analysis and
two previous twin studies concur in the observation that wall
thickness or LVM (I) rather than left ventricular dimension
is affected by a familial (and presumably genetic) predispo-
sition (7,8). Consequently, we observed a familial risk for
the manifestation of concentric LVH and concentric left
ventricular remodeling, both being characterized by in-
creased wall thickness, but not eccentric LVH, which is
Table 4. Prevalence (in %) and Adjusted Odds Ratio of Increased Relative Wall Thickness in
LVH-Siblings and a Comparison Group Matched by Age and Gender, Stratifying by
Hypertension and Overweight
LVH-Sibling
(n 5 319)
Matched
Controls
(n 5 636) p-Value
Normotensives (n 5 332)
(SBP ,140 mm Hg and DBP
,90 mm Hg)
Prevalence of RWT $45% 27.5% 14.7%
Adjusted odds ratio of increased
relative wall thickness
2.2 2* 0.0087
95% confidence interval (1.2–4.0)
Hypertensives (n 5 624)
(SBP $140 mm Hg or DBP
$90 mm Hg)
Prevalence of RWT $45% 49.8% 37.1%
Adjusted odds ratio of increased
relative wall thickness
1.9 2* 0.0003
95% confidence interval (1.4–2.7)
Normal weight (n 5 273)
(BMI ,25 kg/m2)
Prevalence of RWT $45% 33.7% 18.4%
Adjusted odds ratio of increased
relative wall thickness
2.9 2* 0.0014
95% confidence interval (1.5–5.7)
Overweight (n 5 683)
(BMI ,25 kg/m2)
Prevalence of RWT $45% 45.8% 33.6%
Adjusted odds ratio of increased
relative wall thickness
1.8 2* 0.0008
95% confidence interval (1.3–2.5)
*Reference category.
SBP 5 systolic blood pressure; DBP 5 diastolic blood pressure; RWT 5 relative wall thickness; BMI 5 body mass index.
Adjusted by multiple logistic regression models containing gender, age, systolic blood pressure and body mass index.
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predominantly related to an increase in left ventricular
dimension.
Interaction with other determinants of LVH. This study
was carried out on population-based samples to avoid a
preselection of LVH cases, which occurs in the clinical
setting. It should be emphasized, therefore, that about
one-third of the individuals with LVH were normotensive
and with normal BMI and, thus, without traditional risk
factors for LVH. This distribution resembles observations
from other population-based surveys such as the Framing-
ham Heart Study (12,27). We thus conducted subanalyses
that revealed a familial component of increased RWT in
LVH-siblings irrespective of blood pressure or body mass
status. Although an observational study cannot entirely rule
out secondary effects on LV mass, consistent findings after
adjustment as well as stratification by blood pressure and
weight status suggest that the familial risk of LVH, like the
variability of left ventricular mass in twins (3), is not
secondary to a familial predisposition for hypertension or
obesity.
Implications for molecular genetics. Recent molecular
genetic investigations suggested that the risk to present with
LVH may be affected by alterations of specific candidate
genes, such as the angiotensin-converting enzyme gene
(12). Although a series of studies reproduced this observa-
tion, others were not able to confirm the hypothesis (28).
Hence, current molecular genetic studies in humans do not
definitively document a genetic component in the patho-
genesis of LVH, whereas in experimental animals inherited
susceptibility to LVH is well documented (29). Given the
present data on human subjects, the overall familial contri-
bution of LVH can be estimated and, thus, more realistic
power estimations (to confirm or reject a null hypothesis of
genetic association or linkage) for molecular genetic analyses
can be made.
Conclusions. Although a familial and presumably a ge-
netic component in the pathogenesis of LVH is suggested
by this study, we do not wish to distract attention from
measures that have been proven to regress LVH, including
diet, physical activity, and, if indicated, antihypertensive
medication. Furthermore, it remains to be shown that LVH
derived from genetic predisposition confers an increased
cardiovascular risk as has been documented for LVH in
general (24,25). Nevertheless, the present data allow the
reemphasis that several cardiovascular sequelae including
LVH are potentially shared by family members of affected
individuals, providing the opportunity for early recognition
and, possibly, prevention of the associated risk.
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